Depressive and anxiety symptoms among patients with inflammatory bowel diseases

Bielińska, Joanna; Liebert, Ariel; Lesiewska, Natalia; Bieliński, Maciej; Mieczkowski, Artur; Sopońska-Brzoszczyk, Paulina; Brzoszczyk, Bartosz; Długosz, Dominika; Guenter, Wojciech; Borkowska, Alina; Kłopocka, Maria

doi:10.5603/mrj.2017.0002

Cited by 6 publications

(3 citation statements)

References 108 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The literature suggests that excess body weight is highly-associated with the appearance of anxiety and depression symptoms (41,42) . A recent study in Poland with patients with IBD also found significant results regarding overweight and higher levels of depressive symptoms (43) . Finally, it is necessary to point some limitations of the present study.…”

Section: Discussionmentioning

confidence: 95%

Symptoms of Anxiety and Depression, and Quality of Life of Patients With Crohn’s Disease

Tomazoni

Benvegnú

2018

Arq. Gastroenterol.

View full text Add to dashboard Cite

-Background -Crohn's disease is an idiopathic chronic inflammatory disease. It is classified as an inflammatory bowel disease. Crohn's disease can change patient quality of life, especially during flares. Crohn's disease has been associated with symptoms of anxiety and depression, because the clinical symptoms have a high impact on quality of life. Objective -To investigate the prevalence of symptoms of anxiety and depression in Brazilian patients diagnosed with Crohn's disease, as well as their quality of life. Methods -A total of 110 Brazilian patients aged 21-59 years, both genders, with Crohn's disease were included. The data were collected through questionnaires. The Hospital Anxiety and Depression Scale (HADS) was used to assess anxiety and depression symptoms. Quality of life was evaluated using the Inflammatory Bowel Disease Questionnaire. Data were analyzed by ANOVA, followed by the Duncan post-hoc test and the multiple linear regression test. Results -Of the total, 61.7% of participants reported symptoms of anxiety or depression or both. Regarding quality of life, the majority (43.6%) were classified as "regular" and the minority (3.6%) as "excellent". Multiple linear regression showed that worse quality of life correlated with greater presence of anxiety and depression symptoms (<0.001).Conclusion -Crohn's disease has considerable impact on quality of life and contributes to the appearance of anxiety and/or depression symptoms. HEADINGS -Crohn disease. Quality of life. Anxiety. Depression.

show abstract

Section: Discussionmentioning

confidence: 95%

Symptoms of Anxiety and Depression, and Quality of Life of Patients With Crohn’s Disease

Tomazoni

Benvegnú

2018

Arq. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…Epidemiological studies have established that anxiety and depression are the most prevalent psychiatric disorders among IBD patients [ 10 – 13 ]. Also patients suffering from other immune-mediated inflammatory diseases, such as multiple sclerosis or rheumatoid arthitis, are at the increased risk of psychiatric comorbidity [ 14 , 15 ].…”

Section: Introductionmentioning

confidence: 99%

Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation

et al. 2018

Self Cite

View full text Add to dashboard Cite

Psychiatric disorders are significantly common complications among patients suffering from inflammatory bowel diseases (IBD). Affective temperament is a concept of core personality traits, which can decribe the vulnerability to mood disorders, therefore its evaluation might convey useful information about patients' mental status in autoimmune disorders. The aim of the study was to evaluate the affective temperament in patients with Crohn's disease (CD) and ulcerative colitis (UC) as characteristic features of these diseases, but also in the clinical course and the severity of anxiety and depression.Due to our knowledge this is the first study of this kind. The study enrolled 130 patients with IBD, including 68 with CD and 62 with UC. We used TEMPS-A to evaluate affective temperament and HADS scales to assess the intensity of depressive and anxiety symptoms. Harvey Bradshaw scale, Crohn’s Disease Activity Index (CDAI) and Mayo Score were used to evaluate clinical severity of the diseases. We observed significantly higher prevalence of depressive, cyclothymic and anxiety temperaments in CD patients compared to the control group. Harvey Bradshaw scale, CDAI and Mayo Self Report showed statistically significant outcomes, including significant positive correlations with depressive, cyclothymic and anxiety subscales of TEMPS-A, and negative correlation with the hyperthymic temperament in CD subjects. Our findings indicate significant differences between CD and UC due to temperament traits, and suggest distinct pathogenesis of mood disorders in IBD.

show abstract

“…Differences between men and women with IBD has been reported several times [ 33 , 34 ]. In our study, girls perceived more pain at diagnosis and worst flare than boys.…”

Section: Discussionmentioning

confidence: 99%

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO)

Glapa-Nowak

Bukowska-Posadzy

Szczepanik

et al. 2021

IJERPH

View full text Add to dashboard Cite

No gold standard is available to evaluate subjective psychophysical experiences in pediatric inflammatory bowel disease (IBD). We aimed to assess pain, anxiety, and limitations in social activities at diagnosis and the worst flare of the disease in relation to clinical expression, treatment and IBD severity. A total of 376 children completed the survey (Crohn’s disease (CD) n = 196; ulcerative colitis (UC) n = 180). The questionnaire included 12 questions regarding pain, anxiety, and social activity, all assessed at recruitment and retrospectively at diagnosis and worst flare using a numeric rating scale. Patients that had ever been treated with systemic glucocorticosteroids scored higher in pain (p < 0.001), anxiety (p = 0.015), and social activity domains (p < 0.016) at worst flare, and the answers correlated with the number of steroid courses (p < 0.0392). The perception of social activity limitations also correlated independently with the number of immunosuppressants (p < 0.0433) and biological agents (p < 0.0494). There was no difference in retrospective perception of pain, anxiety and social activity limitations between CD and UC patients at diagnosis and the worst flare. The level of limitations in social activity correlated with hospitalisations due to relapse, days spent in the hospital, number of relapses, and severe relapses with the strongest association of rho = 0.39 (p = 0.0004). Subjective and retrospective perception of pain, anxiety, and limitations in social activity differs depending on therapy, correlates with treatment modalities, and severity measures such as hospitalisations.

show abstract

Depressive and anxiety symptoms among patients with inflammatory bowel diseases

Cited by 6 publications

References 108 publications

Symptoms of Anxiety and Depression, and Quality of Life of Patients With Crohn’s Disease

Symptoms of Anxiety and Depression, and Quality of Life of Patients With Crohn’s Disease

Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation

Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO)

Contact Info

Product

Resources

About